[go: up one dir, main page]

PT3011972T - Composição medicinal para promover síntese de protoporfirina ix - Google Patents

Composição medicinal para promover síntese de protoporfirina ix

Info

Publication number
PT3011972T
PT3011972T PT148142953T PT14814295T PT3011972T PT 3011972 T PT3011972 T PT 3011972T PT 148142953 T PT148142953 T PT 148142953T PT 14814295 T PT14814295 T PT 14814295T PT 3011972 T PT3011972 T PT 3011972T
Authority
PT
Portugal
Prior art keywords
protoporphyrin
medicinal composition
promoting synthesis
promoting
synthesis
Prior art date
Application number
PT148142953T
Other languages
English (en)
Inventor
Ishizuka Masahiro
Ota Urara
Kamiya Atsuko
Takahashi Kiwamu
Tanaka Tohru
Ozawa Toshiyuki
Morimoto Kuniyuki
Watanabe Keitaro
Original Assignee
Sbi Pharmaceuticals Co Ltd
Univ Osaka City
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sbi Pharmaceuticals Co Ltd, Univ Osaka City filed Critical Sbi Pharmaceuticals Co Ltd
Publication of PT3011972T publication Critical patent/PT3011972T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/00615-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/40Peroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT148142953T 2013-06-19 2014-06-13 Composição medicinal para promover síntese de protoporfirina ix PT3011972T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013129057 2013-06-19

Publications (1)

Publication Number Publication Date
PT3011972T true PT3011972T (pt) 2019-11-20

Family

ID=52104568

Family Applications (1)

Application Number Title Priority Date Filing Date
PT148142953T PT3011972T (pt) 2013-06-19 2014-06-13 Composição medicinal para promover síntese de protoporfirina ix

Country Status (11)

Country Link
US (1) US9603928B2 (pt)
EP (1) EP3011972B1 (pt)
JP (1) JP6051305B2 (pt)
CN (2) CN112057627A (pt)
DK (1) DK3011972T3 (pt)
ES (1) ES2755303T3 (pt)
HK (1) HK1218628A1 (pt)
HU (1) HUE046458T2 (pt)
PL (1) PL3011972T3 (pt)
PT (1) PT3011972T (pt)
WO (1) WO2014203833A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015522554A (ja) 2012-06-04 2015-08-06 サンコー・エナジー・インコーポレーテッド パラフィン油及び沈降防止剤を含む製剤
HUE046458T2 (hu) 2013-06-19 2020-03-30 Sbi Pharmaceuticals Co Ltd Gyógyászati készítmény protoporfirin IX szintézisének elõsegítésére
WO2017035582A1 (en) * 2015-08-31 2017-03-09 The University Of Adelaide Methods and products for preventing and/or treating microorganism infections comprising iron chelators and non-iron porphyrins
ES3025741T3 (en) * 2017-08-16 2025-06-09 Nutrien Ag Solutions Canada Inc Photodynamic inhibition of microbial pathogens in plants
ES3051057T3 (en) 2019-02-15 2025-12-26 Nutrien Ag Solutions Canada Inc The use of protoporphyrin ix derivatives to improve the health of plants
CN109821017A (zh) * 2019-03-20 2019-05-31 天津医科大学 5-氨基酮戊酸和铁螯合剂在制备抗肿瘤联合用药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07133277A (ja) 1993-11-09 1995-05-23 Yamanouchi Pharmaceut Co Ltd カルバペネム誘導体
US5895786A (en) * 1996-05-08 1999-04-20 New York Blood Center, Inc. Method for treating viral infections
GB0118251D0 (en) * 2001-07-26 2001-09-19 Photocure Asa Method
KR101236257B1 (ko) 2004-06-07 2013-02-22 신젠타 파티서페이션즈 아게 선충 피해를 감소시키는 방법
JP5535808B2 (ja) 2010-07-28 2014-07-02 富士フイルム株式会社 アスタキサンチン含有水系組成物、化粧料、及びアスタキサンチンの分解抑制方法
HUE046458T2 (hu) 2013-06-19 2020-03-30 Sbi Pharmaceuticals Co Ltd Gyógyászati készítmény protoporfirin IX szintézisének elõsegítésére

Also Published As

Publication number Publication date
JP6051305B2 (ja) 2016-12-27
EP3011972A4 (en) 2017-03-01
US20160136274A1 (en) 2016-05-19
HUE046458T2 (hu) 2020-03-30
PL3011972T3 (pl) 2020-02-28
DK3011972T3 (da) 2019-11-04
US9603928B2 (en) 2017-03-28
ES2755303T3 (es) 2020-04-22
WO2014203833A1 (ja) 2014-12-24
EP3011972A1 (en) 2016-04-27
EP3011972B1 (en) 2019-10-23
JPWO2014203833A1 (ja) 2017-02-23
CN105555312A (zh) 2016-05-04
CN112057627A (zh) 2020-12-11
HK1218628A1 (zh) 2017-03-03
HK1221904A1 (en) 2017-06-16

Similar Documents

Publication Publication Date Title
IL287516A (en) Medicinal uses of empagliflozin
PT2818482T (pt) Composição farmacêutica para o tratamento de cancro
HUE045461T2 (hu) Gyógyászati készítmény rák kezelésére
ZA201506487B (en) Therapeutic compounds and compositions
IL264259A (en) Oral formulations of pyrrolidine derivatives
PL3030262T3 (pl) Złożona kompozycja farmaceutyczna
IL241101A0 (en) Medicinal uses of empagliflozin
GB201421334D0 (en) Synthesis of aeizeolite
IL241102B (en) Medicinal uses of empagliflozin
EP2950809A4 (en) PHARMACEUTICAL COMPOSITIONS FOR THE ORAL TREATMENT OF DIABETES
SI2981271T1 (sl) Terapevtske uporabe empagliflozina
EP2953605A4 (en) USE OF A COSMETIC COMPOSITION
SI2812013T1 (sl) Formulacija za zdravljenje SRČ-ja
PL3011972T3 (pl) Kompozycja medyczna do pobudzania syntezy protoporfiryny ix
IL245771A0 (en) Synthesis and compositions of porphyrin compounds
PL2991618T3 (pl) Stabilna kompozycja farmaceutyczna o wysokim stężeniu lewoleukoworyny
ZA201505048B (en) Composition of tiacumicin compounds
IL240119A0 (en) Pharmaceutical compositions for oral treatment of diabetes
HUP1300446A2 (en) Medical cosmetic compositions